Referências
1.
Anonymous. Council on Drugs. Journal of the American Medical Association 163, 1479–1482 (1957).
2.
State v. Milligan, No. 77-CR-11-2908 (Court of Common Pleas, Franklin County, Ohio, 1978). (1978).
3.
Adkins, V. & Lenyoun, M. An Active Treatment Alternative: A Clubhouse Model. The Journal of Cognitive Rehabilitation 22, 22–26 (2004).
4.
Almeida, V. M. de & Neves, A. K. S. Anorexia santa e anorexia contemporânea: o mesmo transtorno em épocas distintas? Revista Médica de Minas Gerais 22, 348–353 (2012).
5.
Arp, D. A steak with a side of mania: Chasing the real story of Howard Hughes and his obsession with peas. Food and Foodways 28, 141–148 (2020).
6.
Baastrup, P. C. & Schou, M. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16, 162–172 (1967).
7.
Baldock, J. & Leichner, P. Re: Psychiatrists’ attitudes to multiple personality disorder. Can J Psychiatry 40, 495–496 (1995).
8.
Ban, T. A. Pharmacotherapy of depression: a historical analysis. J Neural Transm (Vienna) 108, 707–716 (2001).
9.
Banks, C. G. ’Culture’ in culture-bound syndromes: the case of anorexia nervosa. Soc Sci Med 34, 867–884 (1992).
10.
Behnke, S. H. Assessing the criminal responsibility of individuals with multiple personality disorder: legal cases, legal theory. J Am Acad Psychiatry Law 25, 391–399 (1997).
11.
Bell, R. M. Holy Anorexia. (University of Chicago Press, Chicago, 1985).
12.
Berrios, G. E. The History of Mental Symptoms: Descriptive Psychopathology since the Nineteenth Century. (Cambridge University Press, Cambridge, 1996).
13.
Beveridge, A. Voices of the mad: patients’ letters from the Royal Edinburgh Asylum, 1873-1908. Psychol Med 27, 899–908 (1997).
14.
Borch-Jacobsen, M. Sybil—The Making of a Disease: An Interview with Dr. Herbert Spiegel. The New York Review of Books 44, 60–64 (1997).
15.
16.
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria SAS/MS nº 315, de 30 de março de 2016. Aprova o Protocolo Clínico e Diretrizes Terapêuticas do Transtorno Afetivo Bipolar do tipo I. (2016).
17.
Brasil. Ministério da Saúde. Secretaria de Vigilância Sanitária. Portaria SVS/MS nº 344, de 12 de maio de 1998. Aprova o Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial. (1998).
18.
Brasil. Ministério da Saúde. Secretaria de Vigilância Sanitária. Portaria SVS/MS nº 6, de 29 de janeiro de 1999. Aprova a Instrução Normativa da Portaria SVS/MS nº 344/98, sobre substâncias e medicamentos sujeitos a controle especial. (1999).
19.
Brasil. Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada - RDC nº 873, de 27 de maio de 2024. Estabelece critérios e procedimentos para o gerenciamento informatizado da distribuição de numeração de Notificações de Receita e de Talonários de Receituários no território nacional, por meio do Sistema Nacional de Controle de Receituários (SNCR). (2024).
20.
Brasil. Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada - RDC nº 1.000, de 11 de dezembro de 2025. Dispõe sobre os requisitos de controle para Notificações de Receita, Receitas de Controle Especial e Receitas sujeitas à retenção emitidas em meio eletrônico. (2025).
21.
Brown, W. A. Lithium: A Doctor, a Drug, and a Breakthrough. (Liveright Publishing Corporation, New York, 2020).
22.
Brownstein, M. & Solyom, L. The dilemma of Howard Hughes: paradoxical behavior in compulsive disorders. Can J Psychiatry 31, 238–240 (1986).
23.
Brumberg, J. J. Fasting Girls: The Emergence of Anorexia Nervosa as a Modern Disease. (Harvard University Press, Cambridge, MA, 1988).
24.
Burti, L. Italian psychiatric reform 20 plus years after. Acta Psychiatr Scand Suppl 41–46 (2001) doi:10.1034/j.1600-0447.2001.1040s2041.x.
25.
Burton, R. The Anatomy of Melancholy. (W. J. Widdleton, New York, 1875).
26.
Butcher, J. N., Hooley, J. M. & Mineka, S. Abnormal Psychology. (Pearson, Boston, 2013).
27.
Bynum, C. W. Fast, Feast, and Flesh: The Religious Significance of Food to Medieval Women. Representations 1–25 (1985) doi:10.2307/2928425.
28.
Cade, J. F. J. Lithium salts in the treatment of psychotic excitement. Med J Aust 2, 349–352 (1949).
29.
Carlson, E. T. The history of multiple personality in the United States: I: The beginnings. Am J Psychiatry 138, 666–668 (1981).
30.
Carlson, E. T. The history of multiple personality in the United States: Mary Reynolds and her subsequent reputation. Bull Hist Med 58, 72–82 (1984).
31.
Carlson, E. T. Multiple personality and hypnosis: the first one hundred years. J Hist Behav Sci 25, 315–322 (1989).
32.
Cockayne, T. O. Leechdoms, Wortcunning, and Starcraft of Early England: Being a Collection of Documents Illustrating the History of Science in this Country before the Norman Conquest. (Cambridge University Press, Cambridge, 2012).
33.
Conrad, K. La esquizofrenia incipiente: intento de un análisis de la forma del delirio. (Editorial Alhambra, Madrid, 1963).
34.
Cooper, J. E. et al. Psychiatric Diagnosis in New York and London: A Comparative Study of Mental Hospital Admissions. (Oxford University Press, London, 1972).
35.
Corcoran, A. C., Taylor, R. D. & Page, I. H. Lithium poisoning from the use of salt substitutes. J Am Med Assoc 139, 685–688 (1949).
36.
Crosby, W. H. Whatever became of chlorosis? JAMA 257, 2799–2800 (1987).
37.
Crozier, I. Making up koro: multiplicity, psychiatry, culture, and penis-shrinking anxieties. J Hist Med Allied Sci 67, 36–70 (2012).
38.
Curtayne, A. Saint Catherine of Siena. (TAN Books, Charlotte, NC, 2016).
39.
Deutsch, A. Dorothea Lynde Dix: Apostle of the Insane. The American Journal of Nursing 36, 987–997 (1936).
40.
Dinicola, V. F. Anorexia Multiforme: Self-starvation in Historical and Cultural Context. Part I: Self-starvation as a Historical Chameleon. Transcultural Psychiatric Research Review 27, 165–196 (1990).
41.
Doyle, A., Lanoil, J. & Dudek, K. J. Fountain House: Creating Community in Mental Health Practice. (Columbia University Press, New York, 2013).
42.
Dumont, M. P. & Dumont, D. M. Deinstitutionalization in the United States and Italy: A Historical Survey. International Journal of Mental Health 37, 61–70 (2008).
43.
Edwards, M. J., Stone, J. & Lang, A. E. From psychogenic movement disorder to functional movement disorder: it’s time to change the name. Mov Disord 29, 849–852 (2014).
44.
Emling, S. Setting the World on Fire: The Brief, Astonishing Life of St. Catherine of Siena. (St. Martin’s Press, New York, 2016).
45.
Fabrega, H. The concept of somatization as a cultural and historical product of Western medicine. Psychosom Med 52, 653–672 (1990).
46.
Farrell, H. M. Dissociative identity disorder: No excuse for criminal activity. Current Psychiatry 10, 33–40 (2011).
47.
Feighner, J. P. et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26, 57–63 (1972).
48.
Flannery, M. & Glickman, M. Fountain House: Portraits of Lives Reclaimed from Mental Illness. (Hazelden, Center City, MN, 1996).
49.
Foucault, M. Folie et déraison. Histoire de la folie à l’âge classique. (Plon, Paris, 1961).
50.
French, L. Victimization of the mentally ill: an unintended consequence of deinstitutionalization. Soc Work 32, 502–505 (1987).
51.
Friedrich, M. J. Lithium: proving its mettle for 50 years. JAMA 281, 2271–2273 (1999).
52.
Greenspan, S. I. & Wieder, S. The Developmental Individual-Difference, Relationship-Based (DIR/Floortime) Model Approach to Autism Spectrum Disorders. em Clinical Manual for the Treatment of Autism (org. Hollander, E. & Anagnostou, E.) 179–209 (American Psychiatric Publishing, Arlington, VA, 2007).
53.
Grinspoon, L. & Bakalar, J. B. Coca and cocaine as medicines: an historical review. J Ethnopharmacol 3, 149–159 (1981).
54.
Grob, G. N. The attack of psychiatric legitimacy in the 1960s: rhetoric and reality. J Hist Behav Sci 47, 398–416 (2011).
55.
Gureje, O. & Reed, G. M. Bodily distress disorder in ICD-11: problems and prospects. World Psychiatry 15, 291–292 (2016).
56.
Guttmann, E. & Sargant, W. Observations on Benzedrine. Br Med J 1, 1013–1015 (1937).
57.
Hanlon, L. W., Romaine, M., Gilroy, F. J. & Deitrick, J. E. Lithium chloride as a substitute for sodium chloride in the diet; observations on its toxicity. J Am Med Assoc 139, 688–692 (1949).
58.
Harris, J. C. Anorexia nervosa and anorexia mirabilis: Miss K. R–and St Catherine Of Siena. JAMA Psychiatry 71, 1212–1213 (2014).
59.
Hart, O. van der & Dorahy, M. J. History of the Concept of Dissociation. em Dissociation and the Dissociative Disorders: DSM-V and Beyond (org. Dell, P. F. & O’Neil, J. A.) 3–26 (Routledge, New York, 2009).
60.
Healy, D. The Psychopharmacologists III: Interviews. (Arnold, London, 2000).
61.
Hoffman, A., Utley, B. & Ciccarone, D. Improving medical student communication skills through improvisational theatre. Med Educ 42, 537–538 (2008).
62.
James, D. J. & Glaze, L. E. Mental Health Problems of Prison and Jail Inmates. https://bjs.ojp.gov/content/pub/pdf/mhppji.pdf (2006).
63.
Johnson, F. N. The History of Lithium Therapy. (Macmillan, London, 1984).
64.
Kanner, L. Autistic disturbances of affective contact. Nervous Child 2, 217–250 (1943).
65.
Kassin, S. M. The psychology of confession evidence. American Psychologist 52, 221–233 (1997).
66.
Kendell, R. E. et al. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry 25, 123–130 (1971).
67.
King, M. Diagnosis and Treatment of Sylvia Plath and Virginia Woolf. (2018).
68.
Koutsantoni, K. Manic depression in literature: the case of Virginia Woolf. Med Humanit 38, 7–14 (2012).
69.
Kramer, M., Sartorius, N., Jablensky, A. & Gulbinat, W. The ICD-9 classification of mental disorders. A review of its development and contents. Acta Psychiatr Scand 59, 241–262 (1979).
70.
Kroll, J. & Bachrach, B. Sin and mental illness in the Middle Ages. Psychol Med 14, 507–514 (1984).
71.
Laing, R. D. The Politics of Experience and the Bird of Paradise. (Penguin Books, Harmondsworth, 1967).
72.
Lees, A. J. Lithium: a slow burner. J Neurol Neurosurg Psychiatry 91, 335–337 (2020).
73.
Lieberman, J. A. & Ogas, O. Shrinks: The Untold Story of Psychiatry. (Back Bay Books, New York, 2016).
74.
Lipowski, Z. J. What Does the Word "Psychosomatic" Really Mean? A Historical and Semantic Inquiry. em Psychosomatic Medicine and Liaison Psychiatry: Selected Papers 119–137 (Plenum Press, New York, 1985). doi:10.1007/978-1-4613-2509-3_7.
75.
Lipowski, Z. J. Somatization: the concept and its clinical application. Am J Psychiatry 145, 1358–1368 (1988).
76.
Loftus, E. F. The malleability of human memory. Am Sci 67, 312–320 (1979).
77.
Loomer, H. P., Saunders, J. C. & Kline, N. S. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 8, 129–141 (1957).
78.
López-Muñoz, F. & Alamo, C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 15, 1563–1586 (2009).
79.
Loudon, I. S. Chlorosis, anaemia, and anorexia nervosa. Br Med J 281, 1669–1675 (1980).
80.
Loudon, I. S. The diseases called chlorosis. Psychol Med 14, 27–36 (1984).
81.
Lovaas, O. I. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 55, 3–9 (1987).
82.
Mai, F. M. Psychiatrists’ attitudes to multiple personality disorder: a questionnaire study. Can J Psychiatry 40, 154–157 (1995).
83.
Mattelaer, J. J. & Jilek, W. Koro–the psychological disappearance of the penis. J Sex Med 4, 1509–1515 (2007).
84.
McHugh, P. R. & Putnam, F. W. Resolved: multiple personality disorder is an individually and socially created artifact. J Am Acad Child Adolesc Psychiatry 34, 957-962; discussion 962-963 (1995).
85.
McNally, R. J. Remembering Trauma. (Belknap Press of Harvard University Press, Cambridge, MA, 2003).
86.
Medeiros, H., McDaid, D. & Knapp, M. Shifting Care from Hospital to the Community in Europe: Economic Challenges and Opportunities. https://eprints.lse.ac.uk/4275/ (2008).
87.
Menninger, W. C. Psychosomatic medicine; somatization reactions. Psychosom Med 9, 92–97 (1947).
88.
Monroe, D. Asylum: Inside Central State Hospital, Once the World’s Largest Mental Institution. Atlanta Magazine https://www.atlantamagazine.com/great-reads/asylum-inside-central-state-hospital-worlds-largest-mental-institution/ (2015).
89.
Morrissey, J. P. & Goldman, H. H. Care and Treatment of the Mentally Ill in the United States: Historical Developments and Reforms. The ANNALS of the American Academy of Political and Social Science 484, 12–27 (1986).
90.
Musto, D. F. Opium, cocaine and marijuana in American history. Sci Am 265, 40–47 (1991).
91.
Myerson, A. Effect of Benzedrine Sulfate on Mood and Fatigue in Normal and in Neurotic Persons. Archives of Neurology & Psychiatry 36, 816–822 (1936).
92.
Nie, J., Torabi, S., Peck, C., Niles, H. & Encandela, J. Teaching public speaking to medical students. Clin Teach 17, 606–611 (2020).
93.
Niles, C. Examining the Deinstitutionalization Movement in North America. Health Tomorrow: Interdisciplinarity and Internationality 1, 54–83 (2013).
94.
Oaklander, M. New Hope for Depression. Time https://time.com/4876098/new-hope-for-depression/ (2017).
95.
Okasha, A. & Okasha, T. Notes on mental disorders in Pharaonic Egypt. History of Psychiatry 11, 413–424 (2000).
96.
Paris, J. The rise and fall of dissociative identity disorder. J Nerv Ment Dis 200, 1076–1079 (2012).
97.
Patrocínio, S. O. F. José Bonifácio de Andrada e Silva e os estudos químico-mineralógicos: uma vida perpassada por compromissos com o ensino e a sociedade. (Universidade Federal de Juiz de Fora, Juiz de Fora, 2015).
98.
Pletscher, A. The discovery of antidepressants: a winding path. Experientia 47, 4–8 (1991).
99.
Prince, M. The Dissociation of a Personality: A Biographical Study in Abnormal Psychology. (Longmans, Green,; Co., New York; London; Bombay, 1906).
100.
Propst, R. N. Stages in realizing the international diffusion of a single way of working: the clubhouse model. New Dir Ment Health Serv 1997, 53–66 (1997).
101.
Pull, C. B. Current status of knowledge on public-speaking anxiety. Curr Opin Psychiatry 25, 32–38 (2012).
102.
Rampling, D. Ascetic ideals and anorexia nervosa. J Psychiatr Res 19, 89–94 (1985).
103.
Raphael, S. & Stoll, M. A. Assessing the Contribution of the Deinstitutionalization of the Mentally Ill to Growth in the U.S. Incarceration Rate. The Journal of Legal Studies 42, 187–222 (2013).
104.
Revista Manchete. Reportagem sobre Floripes Dornelas de Jesus (’Santa Lola’), Rio Pomba, MG. (1957).
105.
Rider, E. A. & Keefer, C. H. Communication skills competencies: definitions and a teaching toolbox. Med Educ 40, 624–629 (2006).
106.
Rieber, R. W. Hypnosis, false memory and multiple personality: a trinity of affinity. Hist Psychiatry 10, 3–11 (1999).
107.
Schou, M. & Baastrup, P. C. Lithium treatment of manic-depressive disorder. Dosage and control. JAMA 201, 696–698 (1967).
108.
Schou, M., Juel-Nielsen, N., Stromgren, E. & Voldby, H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17, 250–260 (1954).
109.
Selikoff, I. J., Robitzek, E. H. & Ornstein, G. G. Treatment of pulmonary tuberculosis with hydrazide derivatives of isonicotinic acid. J Am Med Assoc 150, 973–980 (1952).
110.
Sharkey, J. It’s a Mad, Mad, Mad, Mad World; You’re Not Bad, You’re Sick. It’s in the Book. The New York Times https://www.nytimes.com/1997/09/28/weekinreview/it-s-a-mad-mad-mad-mad-world-you-re-not-bad-you-re-sick-it-s-in-the-book.html (1997).
111.
Shorter, E. A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. (John Wiley & Sons, New York, 1998).
112.
Shorter, E. Before Prozac: The Troubled History of Mood Disorders in Psychiatry. (Oxford University Press, New York, 2009).
113.
Shorter, E. The history of lithium therapy. Bipolar Disord 11, 4–9 (2009).
114.
Silveira, S. & Elias, C. “Santa Lola”: trajetória social e origem da vocação religiosa da imagem sagrada do interior mineiro. Revista de Ciências Humanas (UFV) 15, 273–292 (2015).
115.
Smith, Kline & French. Benzedrine advertisement. (1941).
116.
Stein, M. B., Walker, J. R. & Forde, D. R. Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification. Arch Gen Psychiatry 53, 169–174 (1996).
117.
Stern, R. L. Severe lithium chloride poisoning with complete recovery; report of case. J Am Med Assoc 139, 710 (1949).
118.
Strobusch, A. D. & Jefferson, J. W. The checkered history of lithium in medicine. Pharm Hist 22, 72–76 (1980).
119.
Sukkar, I., Gagan, M. & Kealy-Bateman, W. The 14th century religious women Margery Kempe and Catherine of Siena can still teach us lessons about eating disorders today. J Eat Disord 5, 23 (2017).
120.
Tarkowski, R. Reflections: Improving Medical Students’ Presentation Skills. J Cancer Educ 32, 935–937 (2017).
121.
Tejwani, V., Ha, D. & Isada, C. Observations: Public Speaking Anxiety in Graduate Medical Education–A Matter of Interpersonal and Communication Skills? J Grad Med Educ 8, 111 (2016).
122.
Telles-Correia, D. & Marques, J. G. Melancholia before the twentieth century: fear and sorrow or partial insanity? Front Psychol 6, 81 (2015).
123.
Tissenbaum, M. J., Harter, H. M. & Friedman, A. P. Organic neurological syndromes diagnosed as functional disorders. J Am Med Assoc 147, 1519–1521 (1951).
124.
Tseng, W. S. The development of psychiatric concepts in traditional Chinese medicine. Arch Gen Psychiatry 29, 569–575 (1973).
125.
Waldman, A. A Nondangerous Person. em Fight of the Century: Writers Reflect on 100 Years of Landmark ACLU Cases (org. Chabon, M. & Waldman, A.) (Avid Reader Press, New York, 2020).
126.
Wallis, C. & Goehner, A. L. A Tale of Two Schools. Time 167, 48–51 (2006).
127.
Watson, K. Perspective: Serious play: teaching medical skills with improvisational theater techniques. Acad Med 86, 1260–1265 (2011).
128.
Weinberg, C., Cordás, T. A. & Albornoz Munoz, P. Santa Rosa de Lima: uma santa anoréxica na América Latina? Revista de Psiquiatria do Rio Grande do Sul 27, 51–56 (2005).
129.
World Health Organization. ICD-11 for Mortality and Morbidity Statistics (Version 04/2019). (2019).
130.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. (World Health Organization, Geneva, 1993).
131.
Simon, G. E., VonKorff, M., Piccinelli, M., Fullerton, C. & Ormel, J. An international study of the relation between somatic symptoms and depression. N Engl J Med 341, 1329–1335 (1999).
132.
Campbell, E. J., Scadding, J. G. & Roberts, R. S. The concept of disease. Br Med J 2, 757–762 (1979).
133.
Noack, C. H. & Trautner, E. M. The lithium treatment of maniacal psychosis. Med J Aust 2, 219–222 (1951).
134.
Middleton, W. & Butler, J. Dissociative identity disorder: an Australian series. Aust N Z J Psychiatry 32, 794–804 (1998).
135.
Thomas, A. Factitious and malingered dissociative identity disorder: clinical features observed in 18 cases. Journal of Trauma & Dissociation 2, 59–77 (2001).
136.
Strasburger, H. & Waldvogel, B. Sight and blindness in the same person: Gating in the visual system. PsyCh Journal 4, 178–185 (2015).
137.
Şar, V., Yargiç, L. İ. & Tutkun, H. Structured interview data on 35 cases of dissociative identity disorder in Turkey. Am J Psychiatry 153, 1329–1333 (1996).
138.
Hippocrate. Aphorismes. (J.-B. Baillière, Paris, 1844).
139.
Weinberg, C. Do ideal ascético ao ideal estético: a evolução histórica da anorexia nervosa. Revista Latinoamericana de Psicopatologia Fundamental 13, 224–237 (2010).
140.
Darwin, C. The Life and Letters of Charles Darwin, Including an Autobiographical Chapter. (John Murray, London, 1887).
141.
Shakespeare, W. Macbeth. (Jaggard e Blount, London, 1623).
142.
Hoffmann, H. Der Struwwelpeter oder lustige Geschichten und drollige Bilder. (Literarische Anstalt, Frankfurt am Main, 1845).
143.
Bleuler, E. Dementia praecox oder Gruppe der Schizophrenien. (Franz Deuticke, Leipzig und Wien, 1911).
144.
Pinel, P. Traité médico-philosophique sur l’aliénation mentale. (Brosson, Paris, 1809).
145.
De Quincey, T. Confessions of an English Opium-Eater. (Taylor; Hessey, London, 1821).
146.
Stevenson, R. L. Strange Case of Dr Jekyll and Mr Hyde. (Longmans, Green & Co., London, 1886).
147.
Gavin, H. On Feigned and Factitious Diseases, Chiefly of Soldiers and Seamen. (John Churchill, London, 1843).
148.
Camus, A. Le Mythe de Sisyphe. (Gallimard, Paris, 1942).
149.
Silveira, N. da. Imagens do Inconsciente. (Alhambra, Rio de Janeiro, 1981).
150.
Machado de Assis, J. M. Dom Casmurro. (Livraria Garnier, Rio de Janeiro, 1899).
151.
Todd, J. & Dewhurst, K. The Othello Syndrome: A Study in the Psychopathology of Sexual Jealousy. Journal of Nervous and Mental Disease 122, 367–374 (1955).
152.
Kingham, M. & Gordon, H. Aspects of Morbid Jealousy. Advances in Psychiatric Treatment 10, 207–215 (2004).
153.
Caldwell, H. The Brazilian Othello of Machado de Assis: A Study of Dom Casmurro. (University of California Press, Berkeley, 1960).
154.
Booth, W. C. The Rhetoric of Fiction. (University of Chicago Press, Chicago, 1983).
155.
Santiago, S. Uma Literatura nos Trópicos: Ensaios sobre Dependência Cultural. (Perspectiva, São Paulo, 1978).
156.
Bortolotti, L. Delusions and Other Irrational Beliefs. (Oxford University Press, Oxford, 2010).
157.
Davies, M., Coltheart, M., Langdon, R. & Breen, N. Monothematic Delusions: Towards a Two-Factor Account. Philosophy, Psychiatry, & Psychology 8, 133–158 (2001).
158.
Sadock, B. J., Sadock, V. A. & Ruiz, P. Compêndio de Psiquiatria: Ciência do Comportamento e Psiquiatria Clínica. (Artmed, Porto Alegre, 2017).
159.
The American Psychiatric Publishing Textbook of Psychiatry. (American Psychiatric Publishing, Washington, DC, 2014).
160.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. (American Psychiatric Association, Washington, DC, 2013).
161.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. (American Psychiatric Association, Washington, DC, 2022).
162.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. (American Psychiatric Association, Washington, DC, 1994).
163.
Dalgalarrondo, P. Psicopatologia e Semiologia dos Transtornos Mentais. (Artmed, Porto Alegre, 2019).
164.
Jaspers, K. Psicopatologia Geral. (Atheneu, Rio de Janeiro).
165.
Porter, R. Madness: A Brief History. (Oxford University Press, Oxford, 2002).
166.
Allen, W. Hypochondria: An Inside Look. (2013).
167.
U.S. Senate Special Committee on Aging. The Consequences of Clutter: How Hoarding Disorder Affects America’s Older Adults, First Responders, and Their Communities. https://www.aging.senate.gov/imo/media/doc/the_consequences_of_clutter.pdf (2024).
169.
Cain, S. Quiet: The Power of Introverts in a World That Can’t Stop Talking. (Crown Publishing Group, New York, 2012).
170.
Wong, Q. J. J. & Rapee, R. M. The Aetiology and Maintenance of Social Anxiety Disorder: A Synthesis of Complementary Theoretical Models and Formulation of a New Integrated Model. Journal of Affective Disorders 203, 84–100 (2016).
172.
Pardes, A. The Woman Who Woke Up in the Future. (2015).
174.
175.
Monroe, S. M. & Harkness, K. L. Is Depression a Chronic Mental Illness? Psychological Medicine 42, 899–902 (2012).
176.
Parker, G. A Diagnostic Bind: Movie Mania and John Nash’s Schizophrenia. Acta Psychiatrica Scandinavica 132, 321–323 (2015).
177.
Weiden, P. J. Why Did John Nash Stop His Medication? Journal of Psychiatric Practice 8, 386–392 (2002).
178.
Capps, D. John Nash, Game Theory, and the Schizophrenic Brain. Journal of Religion and Health 50, 145–162 (2011).
179.
Hicks, J. God’s Lonely Programmer. (2014).
183.
184.
185.
Gilmore, M. Leonard Cohen: Remembering the Life and Legacy of the Poet of Brokenness. (2016).
187.
Showalter, A. Leonard Cohen’s Clinical Depression, Its Medical Treatment, & Its Resolution. (2019).
188.
Walsh, N. P. “I Never Discuss My Mistresses or My Tailors”. (2001).
189.
Silcott, M. A Happy Man. (2001).
190.
Bernhard, B. Angst & Aquavit. (2001).
191.
Khan, M. & Grisham, J. R. Wiping Your Conscience Clean: Investigating the Macbeth Effect in Individuals with High Obsessive-Compulsive Contamination Concerns. Journal of Experimental Psychopathology 9, 2043808718786595 (2018).
192.
Sacks, O. O Homem que Confundiu sua Mulher com um Chapéu e Outras Histórias Clínicas. (Companhia das Letras, São Paulo, 1997).
193.
Feldman, M. D. Playing Sick? Untangling the Web of Munchausen Syndrome, Munchausen by Proxy, Malingering & Factitious Disorder. (Routledge, New York, 2004).
194.
Cunningham, J. M. & Feldman, M. D. Munchausen by Internet: Current Perspectives and Three New Cases. Psychosomatics 52, 185–189 (2011).
195.
Feldman, M. D. Munchausen by Internet: Detecting Factitious Illness and Crisis on the Internet. Southern Medical Journal 93, 669–672 (2000).
196.
Feldman, M. D. & Peychers, M. E. Legal Issues Surrounding the Exposure of “Munchausen by Internet”. Psychosomatics 48, 451–452 (2007).
197.
McCulloch, V. & Feldman, M. D. Munchausen by Proxy by Internet. Child Abuse & Neglect 35, 965–966 (2011).
198.
Newns, K. V. J. & Feldman, M. D. Munchausen by Internet and False Perinatal Crises. Annals of Clinical Psychiatry 33, e8–e12 (2021).
199.
Oxley, J. A. & Feldman, M. D. Munchausen by Proxy by Internet and Pets. Veterinary Record 178, 663–664 (2016).
200.
Pulman, A. & Taylor, J. Munchausen by Internet: Current Research and Future Directions. Journal of Medical Internet Research 14, e115 (2012).
201.
Anderson, C. How to Give a Killer Presentation. Harvard Business Review 91, 121–125 (2013).
202.
Uchida, H., Yamawaki, S., Bahk, W.-M. & Jon, D.-I. Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience. Clinical Psychopharmacology and Neuroscience 14, 115–116 (2016).
203.
Schou, M. Artistic Productivity and Lithium Prophylaxis in Manic-Depressive Illness. British Journal of Psychiatry 135, 97–103 (1979).
204.
Andreasen, N. J. C. & Canter, A. The Creative Writer: Psychiatric Symptoms and Family History. Comprehensive Psychiatry 15, 123–131 (1974).
205.
Ludwig, A. M. Creative Achievement and Psychopathology: Comparison Among Professions. American Journal of Psychotherapy 46, 330–356 (1992).
206.
Ludwig, A. M. Mental Illness and Creative Activity in Female Writers. American Journal of Psychiatry 151, 1650–1656 (1994).
207.
Jamison, K. R. Mood Disorders and Patterns of Creativity in British Writers and Artists. Psychiatry 52, 125–134 (1989).
208.
Andreasen, N. C. The Relationship Between Creativity and Mood Disorders. Dialogues in Clinical Neuroscience 10, 251–255 (2008).
209.
Boeira, M. V., Berni, G. de Á., Passos, I. C., Kauer-Sant’Anna, M. & Kapczinski, F. Virginia Woolf, Neuroprogression, and Bipolar Disorder. Brazilian Journal of Psychiatry 39, 69–71 (2017).
210.
Ghalandari, S. S. A. & Jamili, L. B. Mental Illness and Manic-Depressive Illness in Virginia Woolf’s Mrs. Dalloway. Journal of Novel Applied Sciences 3, 482–489 (2014).
211.
Caramagno, T. C. Manic-Depressive Psychosis and Critical Approaches to Virginia Woolf’s Life and Work. Publications of the Modern Language Association of America (PMLA) 10–23 (1988).
212.
McKay, G. Skinny Blues: Karen Carpenter, Anorexia Nervosa and Popular Music. Popular Music 37, 1–21 (2018).
213.
Baheretibeb, Y., Law, S. & Pain, C. The Girl Who Ate Her House — Pica as an Obsessive-Compulsive Disorder: A Case Report. Clinical Case Studies 7, 3–11 (2008).
214.
Espi Forcen, F. Anorexia Mirabilis: The Practice of Fasting by Saint Catherine of Siena in the Late Middle Ages. American Journal of Psychiatry 170, 370–371 (2013).
215.
Espi Forcen, F. & Espi Forcen, C. The Practice of Holy Fasting in the Late Middle Ages: A Psychiatric Approach. Journal of Nervous and Mental Disease 203, 650–653 (2015).
216.
Rolf, B., Bayer, B. & Anslinger, K. Wonder or Fake — Investigations in the Case of the Stigmatisation of Therese Neumann von Konnersreuth. International Journal of Legal Medicine 120, 105–109 (2006).
217.
Strand, M. René Girard and the Mimetic Nature of Eating Disorders. Culture, Medicine, and Psychiatry 42, 552–583 (2018).
218.
Craddock, N. & Mynors-Wallis, L. Psychiatric Diagnosis: Impersonal, Imperfect and Important. British Journal of Psychiatry 204, 93–95 (2014).
219.
British Psychological Society. Understanding Psychiatric Diagnosis in Adult Mental Health. (2016).
220.
Adam, D. On the Spectrum. Nature 496, 416–418 (2013).
221.
Frances, A. “Transformamos problemas cotidianos em transtornos mentais” (entrevista). (2014).
222.
Smith, R. In Search of “Non-Disease”. BMJ 324, 883–885 (2002).
223.
Pouncey, C. Why Does Psychiatry Need to Define “Mental Disorder”? Revista Latinoamericana de Psicopatologia Fundamental 7, 102–112 (2004).
224.
Johnstone, L. A Straight Talking Introduction to Psychiatric Diagnosis. (PCCS Books, Monmouth, 2014).
225.
Tikkinen, K. A. O., Leinonen, J. S., Guyatt, G. H., Ebrahim, S. & Järvinen, T. L. N. What Is a Disease? Perspectives of the Public, Health Professionals and Legislators. BMJ Open 2, e001632 (2012).
226.
Tikkinen, K. A. O. et al. Public, Health Professional and Legislator Perspectives on the Concept of Psychiatric Disease: A Population-Based Survey. BMJ Open 9, e024265 (2019).
227.
Abel, E. K. Patient Dumping in New York City, 1877–1917. American Journal of Public Health 101, 789–795 (2011).
228.
Ansell, D. A. & Schiff, R. L. Patient Dumping: Status, Implications, and Policy Recommendations. JAMA 257, 1500–1502 (1987).
229.
Kloczko, J. Hospitals Are Dumping Mentally Ill Patients in Los Angeles’ Skid Row. (2016).
230.
Haddon, M. O Estranho Caso do Cachorro Morto. (Editora Record, Rio de Janeiro, 2011).
231.
Baron-Cohen, S. Editorial Perspective: Neurodiversity — A Revolutionary Concept for Autism and Psychiatry. Journal of Child Psychology and Psychiatry 58, 744–747 (2017).
232.
Houting, J. den. Neurodiversity: An Insider’s Perspective. Autism 23, 271–273 (2019).
233.
Jaarsma, P. & Welin, S. Autism as a Natural Human Variation: Reflections on the Claims of the Neurodiversity Movement. Health Care Analysis 20, 20–30 (2012).
234.
Silberman, S. NeuroTribes: The Legacy of Autism and How to Think Smarter About People Who Think Differently. (Allen & Unwin, London, 2016).
235.
Donvan, J. & Zucker, C. In a Different Key: The Story of Autism. (Crown, 2017).
236.
Greenspan, S. I. & Wieder, S. A Functional Developmental Approach to Autism Spectrum Disorders. Journal of the Association for Persons with Severe Handicaps 24, 147–161 (1999).
238.
Swets, J. A. Measuring the Accuracy of Diagnostic Systems. Science 240, 1285–1293 (1988).
239.
Szasz, T. S. Psychiatry, Ethics, and the Criminal Law. Columbia Law Review 58, 183–198 (1958).
240.
Szasz, T. S. The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. (Harper & Row, New York, 1961).
241.
Hymes, K. B. et al. Kaposi’s Sarcoma in Homosexual Men — A Report of Eight Cases. The Lancet 2, 598–600 (1981).
242.
Centers for Disease Control (CDC). Update on Acquired Immune Deficiency Syndrome (AIDS) — United States. MMWR Morbidity and Mortality Weekly Report 31, 507–514 (1982).
243.
Asperger, H. Die “Autistischen Psychopathen” im Kindesalter. Archiv für Psychiatrie und Nervenkrankheiten 117, 76–136 (1944).
244.
Aboraya, A., Rankin, E., France, C., El-Missiry, A. & John, C. The Reliability of Psychiatric Diagnosis Revisited: The Clinician’s Guide to Improve the Reliability of Psychiatric Diagnosis. Psychiatry (Edgmont) 3, 41–50 (2006).
247.
Caplan, P. J. How Do They Decide Who Is Normal? The Bizarre, but True, Tale of the DSM Process. Canadian Psychology / Psychologie canadienne 32, 162–170 (1991).
248.
Frances, A. DSM-IV: Toward a More Empirical Diagnostic System. Canadian Psychology / Psychologie canadienne 32, 171–173 (1991).
249.
Feinstein, A. R. ICD, POR, and DRG: Unsolved Scientific Problems in the Nosology of Clinical Medicine. Archives of Internal Medicine 148, 2269–2274 (1988).
250.
North, C. S. The Classification of Hysteria and Related Disorders: Historical and Phenomenological Considerations. Behavioral Sciences 5, 496–517 (2015).
251.
Moldovan, R., Radu, M., Baban, A. & Dumitrascu, D. L. Evolution of Psychosomatic Diagnosis in DSM: Historical Perspectives and New Development for Internists. Romanian Journal of Internal Medicine 53, 27–32 (2015).
252.
Rief, W. & Isaac, M. The Future of Somatoform Disorders: Somatic Symptom Disorder, Bodily Distress Disorder or Functional Syndromes? Current Opinion in Psychiatry 27, 315–319 (2014).
253.
Scull, A. Hysteria: The Biography. (Oxford University Press, Oxford; New York, 2009).
254.
Fortes, S., Tófoli, L. F. & Gask, L. New Categories of Bodily Stress Syndrome and Bodily Distress Disorder in ICD-11. Jornal Brasileiro de Psiquiatria 67, 211–212 (2018).
255.
Feltz-Cornelis, C. M. van der & Dyck, R. van. The Notion of Somatization: An Artefact of the Conceptualization of Body and Mind. Psychotherapy and Psychosomatics 66, 117–127 (1997).
256.
Gureje, O. Psychiatric Aspects of Pain. Current Opinion in Psychiatry 20, 42–46 (2007).
257.
Greck, M. de. Somatization and Bodily Distress Disorder. em Neuropsychodynamic Psychiatry 319–334 (Springer, 2018).
258.
De Gucht, V. & Fischler, B. Somatization: A Critical Review of Conceptual and Methodological Issues. Psychosomatics 43, 1–9 (2002).
259.
Voigt, K. et al. Towards Positive Diagnostic Criteria: A Systematic Review of Somatoform Disorder Diagnoses and Suggestions for Future Classification. Journal of Psychosomatic Research 68, 403–414 (2010).
260.
Westermarck, E. The History of Human Marriage. (Macmillan, London, 1891).
261.
Wolf, A. P. Childhood Association, Sexual Attraction, and the Incest Taboo: A Chinese Case. American Anthropologist 68, 883–898 (1966).
262.
Wolf, A. P. Adopt a Daughter-in-Law, Marry a Sister: A Chinese Solution to the Problem of the Incest Taboo. American Anthropologist 70, 864–874 (1968).
263.
Wolf, A. P. Childhood Association and Sexual Attraction: A Further Test of the Westermarck Hypothesis. American Anthropologist 72, 503–515 (1970).
264.
Wolf, A. P. & Huang, C. Marriage and Adoption in China, 1845–1945. (Stanford University Press, Stanford, CA, 1980).
265.
Wolf, A. P. Westermarck Redivivus. Annual Review of Anthropology 22, 157–175 (1993).
266.
Wolf, A. P. Sexual Attraction and Childhood Association: A Chinese Brief for Edward Westermarck. (Stanford University Press, Stanford, CA, 1995). doi:10.1515/9780804764681.
267.
Inbreeding, Incest, and the Incest Taboo: The State of Knowledge at the Turn of the Century. (Stanford University Press, Stanford, CA, 2004). doi:10.1515/9780804767415.
268.
Spiro, M. E. Is the Family Universal? American Anthropologist 56, 839–846 (1954).
269.
Talmon, Y. Mate Selection in Collective Settlements. American Sociological Review 29, 491 (1964).
270.
Shepher, J. Mate Selection among Second Generation Kibbutz Adolescents and Adults: Incest Avoidance and Negative Imprinting. Archives of Sexual Behavior 1, 293–307 (1971).
271.
Shepher, J. Incest: A Biosocial View. (Academic Press, New York, 1983).
272.
McCabe, J. FBD Marriage: Further Support for the Westermarck Hypothesis of the Incest Taboo? American Anthropologist 85, 50–69 (1983).
273.
Bevc, I. & Silverman, I. Early Proximity and Intimacy between Siblings and Incestuous Behavior: A Test of the Westermarck Theory. Ethology and Sociobiology 14, 171–181 (1993).
274.
Bevc, I. & Silverman, I. Early Separation and Sibling Incest: A Test of the Revised Westermarck Theory. Evolution and Human Behavior 21, 151–161 (2000).
275.
Lieberman, D., Tooby, J. & Cosmides, L. Does Morality Have a Biological Basis? An Empirical Test of the Factors Governing Moral Sentiments Relating to Incest. Proceedings of the Royal Society B: Biological Sciences 270, 819–826 (2003).
276.
Lieberman, D., Tooby, J. & Cosmides, L. The Architecture of Human Kin Detection. Nature 445, 727–731 (2007).
277.
Fessler, D. M. T. & Navarrete, C. D. Third-Party Attitudes toward Sibling Incest: Evidence for Westermarck’s Hypotheses. Evolution and Human Behavior 25, 277–294 (2004).
278.
Leavitt, G. C. Sociobiological Explanations of Incest Avoidance: A Critical Review of Evidential Claims. American Anthropologist 92, 971–993 (1990).
279.
Lieberman, D. & Symons, D. Sibling Incest Avoidance: From Westermarck to Wolf. The Quarterly Review of Biology 73, 463–466 (1998).
280.
Aijmer, G. The Triumph of a Hypothesis: Edward Westermarck and Almost-Incestuous Chinese Marriages (Review of Wolf 1995). Current Anthropology 39, 174–175 (1998).
281.
Shor, E. & Simchai, D. Incest Avoidance, the Incest Taboo, and Social Cohesion: Revisiting Westermarck and the Case of the Israeli Kibbutzim. American Journal of Sociology 114, 1803–1842 (2009).
282.
Moncrieff, J. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry 28, 3243–3256 (2023).
283.
Horowitz, M. A. & Taylor, D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry 6, 538–546 (2019).
284.
Bromley, C. A Generation on Antidepressants Searches for the Exit. The New York Times (Opinion) https://www.nytimes.com/2026/08/07/opinion/antidepressants-ssris-side-effects-drugs-maha.html (2026).
285.
Barry, E. Top Psychiatrists Call for a Greater Focus on Ceasing Medication. The New York Times https://www.nytimes.com/2026/05/01/science/psychiatry-kennedy-ssris-maha-antidepressants.html (2026).
286.
Davies, J. & Read, J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors 97, 111–121 (2019).
287.
Henssler, J. et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry 11, 526–535 (2024).
288.
Kalfas, M. et al. Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. JAMA Psychiatry 82, 896–907 (2025).
289.
Moncrieff, J. et al. Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review. Psychological Medicine 55, (2025).
290.
Zhang, M.-M. et al. Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review. Molecular Psychiatry 30, 1758–1769 (2024).
291.
Fava, G. A., Gatti, A., Belaise, C., Guidi, J. & Offidani, E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychotherapy and Psychosomatics 84, 72–81 (2015).
292.
Fava, G. A. et al. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review. Psychotherapy and Psychosomatics 87, 195–203 (2018).
293.
Rennwald, A. & Hengartner, M. P. Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis. Epidemiology and Psychiatric Sciences 34, (2025).
294.
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A. & Taylor, D. Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS Drugs 37, 143–157 (2023).
295.
Sørensen, A., Jørgensen, K. J. & Munkholm, K. Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review. Journal of Affective Disorders 316, 177–186 (2022).
296.
Sørensen, A., Ruhé, H. G. & Munkholm, K. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review. Molecular Psychiatry 27, 192–201 (2022).
297.
Shapiro, B. B. Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs. Psychopharmacology 235, 2779–2781 (2018).
298.
Os, J. van & Groot, P. C. Outcomes of hyperbolic tapering of antidepressants. Therapeutic Advances in Psychopharmacology 13, (2023).
299.
O’Neill, J. R., Sørensen, A., Taylor, D. & Horowitz, M. A. Alternate-day dosing to taper antidepressants risks severe withdrawal effects: an in silico analysis. Journal of Affective Disorders 392, 120084 (2026).
300.
Lewis, G. et al. Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine 385, 1257–1267 (2021).
301.
Van Leeuwen, E. et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database of Systematic Reviews https://doi.org/10.1002/14651858.CD013495.pub2 (2021) doi:10.1002/14651858.CD013495.pub2.
302.
Zaccoletti, D. et al. Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis. The Lancet Psychiatry 13, 24–36 (2026).
303.
Kendrick, T. et al. Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial. JAMA Network Open 7, e2418383 (2024).
304.
Gupta, S. & Cahill, J. D. A Prescription for “Deprescribing” in Psychiatry. Psychiatric Services 67, 904–907 (2016).
305.
Goldberg, J. F. et al. Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force. JAMA Network Open 9, e260043 (2026).
306.
Goldberg, J. F. et al. The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus. The British Journal of Psychiatry 1–9 (2026) doi:10.1192/bjp.2026.10580.
307.
Brisnik, V. et al. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method. BMC Medicine 22, (2024).
308.
Brisnik, V. et al. Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards. BMC Medicine 22, (2024).
309.
Dewar-Haggart, R. et al. Predicting intentions towards long-term antidepressant use in the management of people with depression in primary care: A longitudinal survey study. PLOS ONE 20, e0299676 (2025).
310.
Jauhar, S. et al. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry 28, 3149–3152 (2023).
311.
Ang, B., Horowitz, M. & Moncrieff, J. Is the chemical imbalance an “urban legend”? An exploration of the status of the serotonin theory of depression in the scientific literature. SSM - Mental Health 2, 100098 (2022).
312.
Lacasse, J. R. & Leo, J. Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature. PLoS Medicine 2, e392 (2005).
313.
Schroder, H. S., Duda, J. M., Christensen, K., Beard, C. & Björgvinsson, T. Stressors and chemical imbalances: Beliefs about the causes of depression in an acute psychiatric treatment sample. Journal of Affective Disorders 276, 537–545 (2020).
314.
Goodwin, G. M., Price, J., De Bodinat, C. & Laredo, J. Emotional blunting with antidepressant treatments: A survey among depressed patients. Journal of Affective Disorders 221, 31–35 (2017).
315.
Peters, E. M., Balbuena, L. & Lodhi, R. J. Emotional blunting with bupropion and serotonin reuptake inhibitors in three randomized controlled trials for acute major depressive disorder. Journal of Affective Disorders 318, 29–32 (2022).
316.
Healy, D. & Mangin, D. Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence. Epidemiology and Psychiatric Sciences 33, (2024).
317.
Framer, A. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology 11, (2021).
318.
Hengartner, M. P., Schulthess, L., Sørensen, A. & Framer, A. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Therapeutic Advances in Psychopharmacology 10, (2020).
319.
Guy, A., Brown, M., Lewis, S. & Horowitz, M. The “patient voice”: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Therapeutic Advances in Psychopharmacology 10, (2020).
320.
Mahmood, R. et al. The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study. Health Expectations 27, (2024).